BACKGROUND: This study evaluated in a rigorous 18-month randomized controlled trial the efficacy of an enhanced vocational intervention for helping individuals with a recent first schizophrenia episode to return to and remain in competitive work or regular schooling. METHODS:Individual Placement and Support (IPS) was adapted to meet the goals of individuals whose goals might involve either employment or schooling. IPS was combined with a Workplace Fundamentals Module (WFM) for an enhanced, outpatient, vocational intervention. Random assignment to the enhanced integrated rehabilitation program (N = 46) was contrasted with equally intensive clinical treatment at UCLA, including social skills training groups, and conventional vocational rehabilitation by state agencies (N = 23). All patients were provided case management and psychiatric services by the same clinical team and received oral atypical antipsychotic medication. RESULTS: The IPS-WFM combination led to 83% of patients participating in competitive employment or school in the first 6 months of intensive treatment, compared with 41% in the comparison group (p < 0.005). During the subsequent year, IPS-WFM continued to yield higher rates of schooling/employment (92% v. 60%, p < 0.03). Cumulative number of weeks of schooling and/or employment was also substantially greater with the IPS-WFM intervention (45 v. 26 weeks, p < 0.004). CONCLUSIONS: The results clearly support the efficacy of an enhanced intervention focused on recovery of participation in normative work and school settings in the initial phase of schizophrenia, suggesting potential for prevention of disability.
RCT Entities:
BACKGROUND: This study evaluated in a rigorous 18-month randomized controlled trial the efficacy of an enhanced vocational intervention for helping individuals with a recent first schizophrenia episode to return to and remain in competitive work or regular schooling. METHODS: Individual Placement and Support (IPS) was adapted to meet the goals of individuals whose goals might involve either employment or schooling. IPS was combined with a Workplace Fundamentals Module (WFM) for an enhanced, outpatient, vocational intervention. Random assignment to the enhanced integrated rehabilitation program (N = 46) was contrasted with equally intensive clinical treatment at UCLA, including social skills training groups, and conventional vocational rehabilitation by state agencies (N = 23). All patients were provided case management and psychiatric services by the same clinical team and received oral atypical antipsychotic medication. RESULTS: The IPS-WFM combination led to 83% of patients participating in competitive employment or school in the first 6 months of intensive treatment, compared with 41% in the comparison group (p < 0.005). During the subsequent year, IPS-WFM continued to yield higher rates of schooling/employment (92% v. 60%, p < 0.03). Cumulative number of weeks of schooling and/or employment was also substantially greater with the IPS-WFM intervention (45 v. 26 weeks, p < 0.004). CONCLUSIONS: The results clearly support the efficacy of an enhanced intervention focused on recovery of participation in normative work and school settings in the initial phase of schizophrenia, suggesting potential for prevention of disability.
Entities:
Keywords:
(Improving Work Outcome in People with Recent-Onset Schizophrenia, NCT00203788, http://www.clinicaltrials.gov); first-episode schizophrenia; functional outcome; randomized controlled trial; supported education; supported employment; work recovery
Authors: Kim T Mueser; Steve Aalto; Deborah R Becker; John S Ogden; Rosemarie S Wolfe; Diane Schiavo; Charles J Wallace; Haiyi Xie Journal: Psychiatr Serv Date: 2005-10 Impact factor: 3.084
Authors: Robert Rosenheck; Kim T Mueser; Kyaw Sint; Haiqun Lin; David W Lynde; Shirley M Glynn; Delbert G Robinson; Nina R Schooler; Patricia Marcy; Somaia Mohamed; John M Kane Journal: Schizophr Res Date: 2016-09-23 Impact factor: 4.939
Authors: Shirley M Glynn; Stephen R Marder; Douglas L Noordsy; Christopher O'Keefe; Deborah R Becker; Robert E Drake; Catherine A Sugar Journal: Psychiatr Serv Date: 2016-11-01 Impact factor: 3.084
Authors: K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz Journal: Schizophr Bull Date: 1992 Impact factor: 9.306
Authors: M Dol; S Varatharajan; E Neiterman; E McKnight; M Crouch; E McDonald; C Malachowski; N Dali; E Giau; E MacEachen Journal: J Occup Rehabil Date: 2021-04-21
Authors: Gary R Bond; Monirah Al-Abdulmunem; Jessica Marbacher; Thomas N Christensen; Vigdis Sveinsdottir; Robert E Drake Journal: Adm Policy Ment Health Date: 2022-10-11
Authors: Won Jong Chwa; Todd A Tishler; Catalina Raymond; Cathy Tran; Faizan Anwar; J Pablo Villablanca; Joseph Ventura; Kenneth L Subotnik; Keith H Nuechterlein; Benjamin M Ellingson Journal: Schizophr Res Date: 2020-05-31 Impact factor: 4.939
Authors: Isabelle Weld-Blundell; Marissa Shields; Alexandra Devine; Helen Dickinson; Anne Kavanagh; Claudia Marck Journal: Int J Environ Res Public Health Date: 2021-11-17 Impact factor: 3.390
Authors: Jennifer L Humensky; Luana R Turner; Lisa B Dixon; Robert E Drake; Deborah R Becker; Kenneth L Subotnik; Joseph Ventura; Keith H Nuechterlein Journal: Early Interv Psychiatry Date: 2020-04-29 Impact factor: 2.732